CPAP Alternative Non-Inferior for Reducing Blood Pressure, Study Finds
Researchers suggest higher adherence to the CPAP alternative likely contributed to its benefits for people with obstructive sleep apnea and hypertension.
Researchers suggest higher adherence to the CPAP alternative likely contributed to its benefits for people with obstructive sleep apnea and hypertension.
Teledentistry companies historically focus on routine dental procedures. Now, a few combine their direct-to-patient reach with referrals to local dentists to ease the path for people with sleep apnea.
A dental sleep medicine practitioner’s case study shows how alternating therapies—in this case, from CPAP, to oral appliance therapy, back to CPAP, to clear aligners with myofunctional therapy—facilitates sustained adherence.
Vivos announced it is seeing positive preliminary metrics after receiving FDA clearance for its CARE oral appliances to treat severe OSA.
Read MoreUnitedHealthcare’s updated medical policy for obstructive and central sleep apnea establishes oral appliance therapy as a prerequisite therapy for surgical treatment in adult patients with moderate to severe OSA.
Read MoreA Tennessee dentist who has been sued by multiple TMJ and sleep apnea patients over an unproven dental device he invented has said under oath that he never taught dentists to use the device for those ailments—contradicting video footage of him telling dentists how to use it.
Read MoreA recent study reveals that precision oral appliance therapy devices, developed by ProSomnus Inc, are effective in treating patients with obstructive sleep apnea.
Read MoreA clinical trial demonstrating the efficacy of an EPAP accessory used with an oral appliance for the treatment of obstructive sleep apnea was awarded the CHEST 2023 Top Abstract Poster Award.
Read MoreVivos Therapeutics reported a decrease in revenue for the third quarter, juxtaposed against its efforts to expand internationally and form strategic partnerships in the sleep treatment market.
Read MoreProSomnus Inc, a manufacturer of oral appliance therapy, reported record third-quarter revenue, marking its seventh consecutive quarter of revenue growth.
Read MoreVivos Therapeutics signed a US nationwide agreement with Lincare, a supplier of in-home respiratory therapy products and services, for the distribution of Vivos’ oral appliances.
Read MoreVivos Therapeutics’ flagship daytime-nighttime appliance (DNA) will be tested against CPAP in a clinical trial at Stanford Medicine.
Read MoreVivos Therapeutics Inc signed an exclusive distribution agreement to bolster its international expansion across the Middle East-North Africa region.
Read MoreProSomnus raised $10 million in a convertible preferred equity offering to fuel growth and improve operations.
Read MoreOpen Airway Dental Solutions Ltd, a Canadian medical technology company involved in the marketing and distribution of sleep dentistry-related products, acquired Australia-based oral appliance maker Oventus Medical Ltd earlier this year.
Read MoreThe data adds to the volume of independent evidence establishing precision oral devices as a leading treatment option for OSA, according to the company.
Read MoreUpdated clinical trial data indicate that the First Line Obstructive Sleep Apnea Treatment study, comparing precision oral appliance therapy and CPAP, is on track to achieve all endpoints, according to Prosomnus.
Read MoreVivos Therapeutics reported a decline in product revenue and enrollments in the second quarter, a dip it attributed to governmental investigations into third parties offering non-FDA-approved sleep apnea treatments.
Read More